Company Profile

Enalare Therapeutics Inc
Profile last edited on: 10/19/23      CAGE: 8G2D2      UEI: MDJFW877BCV6

Business Identifier: Novel therapies for life-threatening acute respiratory and critical care conditions.
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

161 Hodge Road
Princeton, NJ 08540
   (908) 399-3980
   contact@enalare.com.
   www.enalare.com
Location: Single
Congr. District: 12
County: Mercer

Public Profile

Extracted word for word from firm's website - no idi input: "Enalare Therapeutics is a privately owned clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions. We have assembled a talented team with extensive pharmaceutical experience across all critical functions, focused on advancing our innovative products through development, regulatory review and launch."

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Dan Motto

  Joseph Pergolizzi

Company News

There are no news available.